Medicine
Docivyx 20 mg/2 mL injection
Docivyx 20 mg/2 mL injection is a prescription medicine containing Docetaxel for intravenous use, marketed by Avyxa Pharma, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Freezing does not adversely affect the product. Store between 2°C and 25°C…
Key facts
- Active ingredient (INN)
- Docetaxel
- Brand
- Docivyx
- Strength
- 20 mg/2 mL
- Dosage form
- Injection
- Route
- Intravenous
- Packs
- 1 vial of 2 mL
- Marketing authorisation holder
- Avyxa Pharma
- Manufacturer
- Avyxa Pharma
- Origin register
- US FDA, United States
- Storage
- Freezing does not adversely affect the product. Store between 2°C and 25°C (36°F and 77°F). Retain in the original package to protect from light.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- L01CD02 Docetaxel
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 9 May 2024
- Identifiers
- RxCUI 1860619, 2679779, 2679784 +3DailyMed set ID 4763744e-360e-4d37-be05-cce4114548cdNDC 83831-101Application NDA215813
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 vial, glass in 1 carton / 2 mL in 1 vial, glass | 83831-101-02 | Avyxa Pharma | 9 May 2024 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Docetaxel 20 mg/2 mL injection.
Other strengths and forms of Docetaxel
Clinical summary
Docetaxel is a microtubule inhibitor indicated for breast Cancer (BC), among other approved uses. It is available as injection and kits for intravenous use. MedsAcross supplies Docetaxel for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about DocetaxelFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Docetaxel prescribing information (Sanofi-Aventis) · U.S. National Library of Medicine, DailyMed
- Taxotere: European public assessment report (EPAR) · European Medicines Agency
- Docetaxel Accord: European public assessment report (EPAR) · European Medicines Agency
Need Docivyx 20 mg/2 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.